scFv-based biologics in diabetes: from therapeutic potential to clinical prospects
The global epidemic of diabetes mellitus the limitations of current therapies-including waning efficacy, adverse effects, and inability to modify disease progression-have accelerated the shift from conventional pharmacotherapy toward biologic agents. T…